DeepCura vs Sully.ai (2026)
Two agent suites that stopped being scribes some time ago, and both should be evaluated on what they do after the note. DeepCura runs eight named agents covering pre visit history, documentation, diagnosis mapping, allergy reconciliation, order generation and billing, with per field write back and the most complete published pricing ladder in this category. Sully sells role based agents for reception, scribing, coding, intake, triage and interpretation across the major record systems, publishes genuine technical work, and prices a bundle at a modest per provider rate. The uncomfortable common ground is autonomy: both draft orders and codes, both act on the record, and neither publishes a confidence threshold, an escalation path or an accuracy figure for any of it. Pilot them on how often a clinician edits what the agents produced, not on how many agents there are.
- The full per seat volume ladder is published, which is the most complete commercial disclosure located anywhere in this category, so a practice can price the whole platform before speaking to anyone.
- The architecture is eight named agents with defined scopes and per field write back, which is a clearer account of what each part does than a single assistant claim.
- A business associate agreement is offered to all covered entities rather than gated behind a tier, and the deployment question is answered by name rather than left open.
- The role based framing covers the whole encounter, reception through coding and triage, integrated with the major record systems, so one vendor spans the front desk and the exam room.
- It publishes real technical work rather than adjectives, including a benchmark result that is unflattering to its own category.
- A public trust centre lists its security, privacy and AI governance documentation in one place, so procurement knows exactly what to request.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. DeepCura and Sully.ai are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | DeepCura | Sully.ai |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2023 | Not recorded |
| Headquarters | Not recorded | San Francisco, California, United States |
| Website | deepcura.com | sully.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards DeepCura its top capability grade on AI Centrality and Commercial Transparency. Set against Sully.ai, DeepCura grades higher on Deployment Model and Data Residency and Commercial Transparency. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Sully.ai its top capability grade on AI Centrality. Set against DeepCura, Sully.ai grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose DeepCura or Sully.ai?
On the axes where the AI Health Index separates them, DeepCura grades higher on Deployment Model and Data Residency and Commercial Transparency, and Sully.ai grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Security Certifications and Trust Center. Sully.ai leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do DeepCura and Sully.ai differ most?
The widest separation the AI Health Index records between DeepCura and Sully.ai is on Commercial Transparency, where DeepCura grades A and Sully.ai grades C. That axis sits in the Commercial group, so it should carry the most weight for a buyer whose binding constraint is contracting, scope and what the price actually covers.
Where do DeepCura and Sully.ai grade the same?
The AI Health Index grades DeepCura and Sully.ai the same on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have DeepCura and Sully.ai not disclosed?
At the last review, at least one of DeepCura and Sully.ai published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
An earlier version of this comparison said Sully's tiered pricing is reported at a modest per provider rate, and that neither vendor publishes a governance framework. Sully's pricing is customised and published by no tier, so the first rested on third party material and is removed; Sully's trust centre lists an AI Governance document behind its access request. Corrected 15 September 2026.
Both platforms take autonomous action well beyond writing a note, drafting orders, codes and patient facing responses, and neither publishes a confidence threshold, an escalation behaviour or an accuracy figure for any of it. That is the central gap in this part of the category: the surface expanded faster than the disclosure. Read one phrase carefully on DeepCura, which describes itself in language implying an attestation it has not evidenced; ask for the report and its type. Neither publishes a fairness statement, subgroup analysis or accent and dialect performance. Sully's trust centre lists an AI Governance document and AI Software Use Guidance behind its access request, and DeepCura publishes no governance framework; neither publishes governance material a buyer can read without asking. Ask both what proportion of generated orders and codes are edited before they are signed.